Qinghai Spring Medicinal Resources Technology Co Ltd (600381) - Total Liabilities
Based on the latest financial reports, Qinghai Spring Medicinal Resources Technology Co Ltd (600381) has total liabilities worth CN¥36.47 Million CNY (≈ $5.34 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Qinghai Spring Medicinal Resources Techn long-term investment allocation to see how much of total assets are deployed in long-term investments.
Qinghai Spring Medicinal Resources Technology Co Ltd - Total Liabilities Trend (1998–2025)
This chart illustrates how Qinghai Spring Medicinal Resources Technology Co Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see 600381 total assets.
Qinghai Spring Medicinal Resources Technology Co Ltd Competitors by Total Liabilities
The table below lists competitors of Qinghai Spring Medicinal Resources Technology Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Suncha Technology Co Ltd
SHE:001211
|
China | CN¥1.17 Billion |
|
Ranpak Holdings Corp
NYSE:PACK
|
USA | $576.80 Million |
|
Xinjiang West Animal Husbandry
SHE:300106
|
China | CN¥561.20 Million |
|
Fusion Micro Finance Limited
NSE:FUSION
|
India | Rs58.39 Billion |
|
Shenzhen Longood Intelligent Electric Co Ltd Class A
SHE:300543
|
China | CN¥749.91 Million |
|
Ribbon Communications Inc
NASDAQ:RBBN
|
USA | $750.25 Million |
|
Liton Technology
TWO:6175
|
Taiwan | NT$1.28 Billion |
|
Dinkelacker AG
STU:DWB
|
Germany | €80.74 Million |
Liability Composition Analysis (1998–2025)
This chart breaks down Qinghai Spring Medicinal Resources Technology Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See 600381 equity to assets ratio to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 17.66 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.04 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.04 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Qinghai Spring Medicinal Resources Technology Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Qinghai Spring Medicinal Resources Technology Co Ltd (1998–2025)
The table below shows the annual total liabilities of Qinghai Spring Medicinal Resources Technology Co Ltd from 1998 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥44.87 Million ≈ $6.57 Million |
-64.96% |
| 2024-12-31 | CN¥128.02 Million ≈ $18.73 Million |
+39.17% |
| 2023-12-31 | CN¥91.99 Million ≈ $13.46 Million |
+249.80% |
| 2022-12-31 | CN¥26.30 Million ≈ $3.85 Million |
-4.85% |
| 2021-12-31 | CN¥27.64 Million ≈ $4.04 Million |
-79.84% |
| 2020-12-31 | CN¥137.08 Million ≈ $20.06 Million |
+580.80% |
| 2019-12-31 | CN¥20.14 Million ≈ $2.95 Million |
-61.78% |
| 2018-12-31 | CN¥52.68 Million ≈ $7.71 Million |
-53.61% |
| 2017-12-31 | CN¥113.56 Million ≈ $16.62 Million |
-45.13% |
| 2016-12-31 | CN¥206.95 Million ≈ $30.28 Million |
-41.64% |
| 2015-12-31 | CN¥354.60 Million ≈ $51.89 Million |
-68.53% |
| 2014-12-31 | CN¥1.13 Billion ≈ $164.88 Million |
-21.69% |
| 2013-12-31 | CN¥1.44 Billion ≈ $210.56 Million |
-24.25% |
| 2012-12-31 | CN¥1.90 Billion ≈ $277.97 Million |
+17.40% |
| 2011-12-31 | CN¥1.62 Billion ≈ $236.77 Million |
+72.39% |
| 2010-12-31 | CN¥938.58 Million ≈ $137.34 Million |
+78.57% |
| 2009-12-31 | CN¥525.60 Million ≈ $76.91 Million |
-10.77% |
| 2008-12-31 | CN¥589.02 Million ≈ $86.19 Million |
-16.76% |
| 2007-12-31 | CN¥707.61 Million ≈ $103.55 Million |
-18.04% |
| 2006-12-31 | CN¥863.38 Million ≈ $126.34 Million |
-17.39% |
| 2005-12-31 | CN¥1.05 Billion ≈ $152.93 Million |
-14.60% |
| 2004-12-31 | CN¥1.22 Billion ≈ $179.07 Million |
+54.93% |
| 2003-12-31 | CN¥789.85 Million ≈ $115.58 Million |
+89.91% |
| 2002-12-31 | CN¥415.90 Million ≈ $60.86 Million |
+56.98% |
| 2001-12-31 | CN¥264.94 Million ≈ $38.77 Million |
+41.00% |
| 2000-12-31 | CN¥187.91 Million ≈ $27.50 Million |
+46.76% |
| 1999-12-31 | CN¥128.04 Million ≈ $18.74 Million |
+7.16% |
| 1998-12-31 | CN¥119.48 Million ≈ $17.48 Million |
-- |
About Qinghai Spring Medicinal Resources Technology Co Ltd
Qinghai Spring Medicinal Resources Technology Co., Ltd. manufactures and sells alcoholic beverages and health products in China. It operates through two segments, Wine and Beverage Fast-Moving Consumer Goods and Big Health. The Wine and Beverage Fast-Moving Consumer Goods segment focuses on the sales of alcoholic beverages, including the Tinghua series wines. The Big Health segment engages in the… Read more